Status:

UNKNOWN

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Lead Sponsor:

Ahmed Ahm

Conditions:

Breast Cancer

Eligibility:

FEMALE

18-75 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to compare the efficacy and toxicities of hypofractionated radiotherapy with conventional fractionated radiotherapy in high risk breast cancer patients treated with mastec...

Detailed Description

Eligible breast cancer patients with mastectomy and axillary dissection are divided into two groups: conventional fractionated (CF) radiotherapy of 50 Gray (GY) in 25 fractions within 5 weeks to ipsil...

Eligibility Criteria

Inclusion

  • Ipsilateral clinically diagnosed and histologically confirmed invasive breast cancer
  • Undergone total mastectomy and axillary dissection T 3-4 and/or 4 or more positive axillary lymph nodes.
  • Fit for chemotherapy ( if indicated) , endocrine therapy (if indicated), and postoperative irradiation.
  • Written informed concent.
  • C T3-4 , or C N2, or pathological positive axillary lymph nodes during mastectomy for patients who had received neoadjuvant chemotherapy or hormone therapy.
  • No supraclavicular or internal mammary nodes metastases.
  • No distant metastases .Enrollment date no more than 8 months after surgery or no more than 2 months after chemotherapy for patients who did't receive neoadjuvant therapy.
  • Enrollment date no more than 2 months after surgery for patients who had received neoadjuvant systemic therapy and did't need adjuvant chemotherapy.

Exclusion

  • Patients who undergone previous irradiation to the ipsilateral chest wall and supraclavicular region
  • Previous or concurrent malignant other than non melanomatous skin cancer
  • Bilateral breast cancer.
  • Immediate or delayed ipsilateral breast cancer reconstruction.

Key Trial Info

Start Date :

October 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2019

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT03319069

Start Date

October 1 2017

End Date

September 1 2019

Last Update

October 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assiut faculty of medicine , clinical oncology and nuclear medicine department

Asyut, Egypt, 088